Human O-sulfated metabolites of (−)-epicatechin and methyl-(−)-epicatechin are poor substrates for commercial aryl-sulfatases: Implications for studies concerned with quantifying epicatechin bioavailability

Epicatechin is a widely consumed dietary flavonoid and there is substantial evidence that it contributes to the health benefits reported for flavanol-rich cocoa products including dark chocolate. Numerous reports have described the appearance of epicatechin and epicatechin phase-2 conjugates (sulfat...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Pharmacological research 2012-06, Vol.65 (6), p.592-602
Hauptverfasser: Saha, S., Hollands, W., Needs, P.W., Ostertag, L.M., de Roos, B., Duthie, G.G., Kroon, P.A.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 602
container_issue 6
container_start_page 592
container_title Pharmacological research
container_volume 65
creator Saha, S.
Hollands, W.
Needs, P.W.
Ostertag, L.M.
de Roos, B.
Duthie, G.G.
Kroon, P.A.
description Epicatechin is a widely consumed dietary flavonoid and there is substantial evidence that it contributes to the health benefits reported for flavanol-rich cocoa products including dark chocolate. Numerous reports have described the appearance of epicatechin and epicatechin phase-2 conjugates (sulfates and glucuronides of epicatechin and methylepicatechin) in blood and urine samples of subjects following ingestion of epicatechin. The most widely reported method of quantifying total epicatechin in plasma and urine samples involves hydrolysis with a mixture of β-glucuronidase and sulfatase to convert the conjugates to epicatechin aglycone which is subsequently quantified. We observed a lack of hydrolysis of epicatechin sulfates and methylepicatechin sulfates using commercial sulfatases and investigated this further. Samples of urine or plasma from subjects who had consumed epicatechin were subjected to enzyme hydrolysis and then analysed using LC–MS/MS, or analysed without enzyme hydrolysis. Attempts to increase the extent of hydrolysis of epicatechin conjugates were made by increasing the amount of enzyme, hydrolysis pH and length of incubations, and using alternative sources of enzyme. The standard hydrolysis conditions failed to hydrolyse the majority of epicatechin sulfates and methylepicatechin sulfates. Even when the quantity of enzyme and incubation period was increased, the pH optimised, or alternative sources of sulfatases were used, epicatechin monosulfates and methylepicatechin monosulfates remained as major peaks in the chromatograms of the samples. An assessment of literature data strongly suggested that the majority of reports where enzyme hydrolysis was used had significantly underestimated epicatechin bioavailability in humans. Methods for quantifying epicatechin concentrations in blood and urine need to take account of the lack of hydrolysis of (methyl)epicatechin-sulfates, for example by quantifying these directly using LC–MS/MS.
doi_str_mv 10.1016/j.phrs.2012.02.005
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1837310464</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1043661812000230</els_id><sourcerecordid>1010496084</sourcerecordid><originalsourceid>FETCH-LOGICAL-c389t-e16cfc75e14e6a0ac2ecee1255671df6782d01b081c4d7e2a35a1c9bc45422d73</originalsourceid><addsrcrecordid>eNqFkUFu1TAQhi1ERUvhAiyQl-0iD9tJnASxQRXQSpW6KWvLsSc8Pzl2ajut3g1Y92gcgZPgkIJYoFayZFvz_f-M5kfoDSUbSih_t9tM2xA3jFC2IfmQ-hk6oqTjBaUtf768q7LgnLaH6GWMO0JIV1HyAh0yVjYlr9sj9ON8HqXDV0Wc7SATaDxCkr23JkHEfsAnP7_fnxYwGZWramsclu43tN3b4j_FAHjyPuA49zEFubgM-av8OEJQRtqMZOXaTkaI7_HFONnFwXi3wjHN2mSh8k5BcHmoO5O2-GaWLplhb9w3_G_P3nh5K42Vvclj71-hg0HaCK8f7mP09fOn67Pz4vLqy8XZx8tClW2XCqBcDaqpgVbAJZGKgQKgrK55Q_XAm5ZpQnvSUlXpBpgsa0lV16uqrhjTTXmMTlbfKfibGWISo4kKrJUO_BwFbfOScwS8eholmes4aReUragKPsYAg5iCGfPOMrRwXOzEErtYYhckH1Jn0dsH_7kfQf-V_Mk5Ax9WAPJCbg0EEZWBvF1tAqgktDeP-f8CgVbF-A</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1010496084</pqid></control><display><type>article</type><title>Human O-sulfated metabolites of (−)-epicatechin and methyl-(−)-epicatechin are poor substrates for commercial aryl-sulfatases: Implications for studies concerned with quantifying epicatechin bioavailability</title><source>Elsevier ScienceDirect Journals Complete - AutoHoldings</source><source>MEDLINE</source><creator>Saha, S. ; Hollands, W. ; Needs, P.W. ; Ostertag, L.M. ; de Roos, B. ; Duthie, G.G. ; Kroon, P.A.</creator><creatorcontrib>Saha, S. ; Hollands, W. ; Needs, P.W. ; Ostertag, L.M. ; de Roos, B. ; Duthie, G.G. ; Kroon, P.A.</creatorcontrib><description>Epicatechin is a widely consumed dietary flavonoid and there is substantial evidence that it contributes to the health benefits reported for flavanol-rich cocoa products including dark chocolate. Numerous reports have described the appearance of epicatechin and epicatechin phase-2 conjugates (sulfates and glucuronides of epicatechin and methylepicatechin) in blood and urine samples of subjects following ingestion of epicatechin. The most widely reported method of quantifying total epicatechin in plasma and urine samples involves hydrolysis with a mixture of β-glucuronidase and sulfatase to convert the conjugates to epicatechin aglycone which is subsequently quantified. We observed a lack of hydrolysis of epicatechin sulfates and methylepicatechin sulfates using commercial sulfatases and investigated this further. Samples of urine or plasma from subjects who had consumed epicatechin were subjected to enzyme hydrolysis and then analysed using LC–MS/MS, or analysed without enzyme hydrolysis. Attempts to increase the extent of hydrolysis of epicatechin conjugates were made by increasing the amount of enzyme, hydrolysis pH and length of incubations, and using alternative sources of enzyme. The standard hydrolysis conditions failed to hydrolyse the majority of epicatechin sulfates and methylepicatechin sulfates. Even when the quantity of enzyme and incubation period was increased, the pH optimised, or alternative sources of sulfatases were used, epicatechin monosulfates and methylepicatechin monosulfates remained as major peaks in the chromatograms of the samples. An assessment of literature data strongly suggested that the majority of reports where enzyme hydrolysis was used had significantly underestimated epicatechin bioavailability in humans. Methods for quantifying epicatechin concentrations in blood and urine need to take account of the lack of hydrolysis of (methyl)epicatechin-sulfates, for example by quantifying these directly using LC–MS/MS.</description><identifier>ISSN: 1043-6618</identifier><identifier>EISSN: 1096-1186</identifier><identifier>DOI: 10.1016/j.phrs.2012.02.005</identifier><identifier>PMID: 22373658</identifier><language>eng</language><publisher>Netherlands: Elsevier Ltd</publisher><subject>Absorption ; Administration, Oral ; Arylsulfatases - metabolism ; Biological Availability ; Biotransformation ; Catechin - administration &amp; dosage ; Catechin - analogs &amp; derivatives ; Catechin - blood ; Catechin - metabolism ; Catechin - urine ; Chromatography, Liquid ; Cross-Over Studies ; Dietary bioactives ; England ; Female ; Flavonoids ; Glucuronidase - metabolism ; Human metabolism ; Humans ; Hydrogen-Ion Concentration ; Hydrolysis ; Male ; Methylation ; Phase-2 enzymes ; Phenolics ; Polyphenols ; Reproducibility of Results ; Substrate Specificity ; Sulfuric Acid Esters - administration &amp; dosage ; Sulfuric Acid Esters - blood ; Sulfuric Acid Esters - metabolism ; Sulfuric Acid Esters - urine ; Tandem Mass Spectrometry ; Time Factors</subject><ispartof>Pharmacological research, 2012-06, Vol.65 (6), p.592-602</ispartof><rights>2012 Elsevier Ltd</rights><rights>Copyright © 2012 Elsevier Ltd. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c389t-e16cfc75e14e6a0ac2ecee1255671df6782d01b081c4d7e2a35a1c9bc45422d73</citedby><cites>FETCH-LOGICAL-c389t-e16cfc75e14e6a0ac2ecee1255671df6782d01b081c4d7e2a35a1c9bc45422d73</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.phrs.2012.02.005$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3549,27923,27924,45994</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/22373658$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Saha, S.</creatorcontrib><creatorcontrib>Hollands, W.</creatorcontrib><creatorcontrib>Needs, P.W.</creatorcontrib><creatorcontrib>Ostertag, L.M.</creatorcontrib><creatorcontrib>de Roos, B.</creatorcontrib><creatorcontrib>Duthie, G.G.</creatorcontrib><creatorcontrib>Kroon, P.A.</creatorcontrib><title>Human O-sulfated metabolites of (−)-epicatechin and methyl-(−)-epicatechin are poor substrates for commercial aryl-sulfatases: Implications for studies concerned with quantifying epicatechin bioavailability</title><title>Pharmacological research</title><addtitle>Pharmacol Res</addtitle><description>Epicatechin is a widely consumed dietary flavonoid and there is substantial evidence that it contributes to the health benefits reported for flavanol-rich cocoa products including dark chocolate. Numerous reports have described the appearance of epicatechin and epicatechin phase-2 conjugates (sulfates and glucuronides of epicatechin and methylepicatechin) in blood and urine samples of subjects following ingestion of epicatechin. The most widely reported method of quantifying total epicatechin in plasma and urine samples involves hydrolysis with a mixture of β-glucuronidase and sulfatase to convert the conjugates to epicatechin aglycone which is subsequently quantified. We observed a lack of hydrolysis of epicatechin sulfates and methylepicatechin sulfates using commercial sulfatases and investigated this further. Samples of urine or plasma from subjects who had consumed epicatechin were subjected to enzyme hydrolysis and then analysed using LC–MS/MS, or analysed without enzyme hydrolysis. Attempts to increase the extent of hydrolysis of epicatechin conjugates were made by increasing the amount of enzyme, hydrolysis pH and length of incubations, and using alternative sources of enzyme. The standard hydrolysis conditions failed to hydrolyse the majority of epicatechin sulfates and methylepicatechin sulfates. Even when the quantity of enzyme and incubation period was increased, the pH optimised, or alternative sources of sulfatases were used, epicatechin monosulfates and methylepicatechin monosulfates remained as major peaks in the chromatograms of the samples. An assessment of literature data strongly suggested that the majority of reports where enzyme hydrolysis was used had significantly underestimated epicatechin bioavailability in humans. Methods for quantifying epicatechin concentrations in blood and urine need to take account of the lack of hydrolysis of (methyl)epicatechin-sulfates, for example by quantifying these directly using LC–MS/MS.</description><subject>Absorption</subject><subject>Administration, Oral</subject><subject>Arylsulfatases - metabolism</subject><subject>Biological Availability</subject><subject>Biotransformation</subject><subject>Catechin - administration &amp; dosage</subject><subject>Catechin - analogs &amp; derivatives</subject><subject>Catechin - blood</subject><subject>Catechin - metabolism</subject><subject>Catechin - urine</subject><subject>Chromatography, Liquid</subject><subject>Cross-Over Studies</subject><subject>Dietary bioactives</subject><subject>England</subject><subject>Female</subject><subject>Flavonoids</subject><subject>Glucuronidase - metabolism</subject><subject>Human metabolism</subject><subject>Humans</subject><subject>Hydrogen-Ion Concentration</subject><subject>Hydrolysis</subject><subject>Male</subject><subject>Methylation</subject><subject>Phase-2 enzymes</subject><subject>Phenolics</subject><subject>Polyphenols</subject><subject>Reproducibility of Results</subject><subject>Substrate Specificity</subject><subject>Sulfuric Acid Esters - administration &amp; dosage</subject><subject>Sulfuric Acid Esters - blood</subject><subject>Sulfuric Acid Esters - metabolism</subject><subject>Sulfuric Acid Esters - urine</subject><subject>Tandem Mass Spectrometry</subject><subject>Time Factors</subject><issn>1043-6618</issn><issn>1096-1186</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkUFu1TAQhi1ERUvhAiyQl-0iD9tJnASxQRXQSpW6KWvLsSc8Pzl2ajut3g1Y92gcgZPgkIJYoFayZFvz_f-M5kfoDSUbSih_t9tM2xA3jFC2IfmQ-hk6oqTjBaUtf768q7LgnLaH6GWMO0JIV1HyAh0yVjYlr9sj9ON8HqXDV0Wc7SATaDxCkr23JkHEfsAnP7_fnxYwGZWramsclu43tN3b4j_FAHjyPuA49zEFubgM-av8OEJQRtqMZOXaTkaI7_HFONnFwXi3wjHN2mSh8k5BcHmoO5O2-GaWLplhb9w3_G_P3nh5K42Vvclj71-hg0HaCK8f7mP09fOn67Pz4vLqy8XZx8tClW2XCqBcDaqpgVbAJZGKgQKgrK55Q_XAm5ZpQnvSUlXpBpgsa0lV16uqrhjTTXmMTlbfKfibGWISo4kKrJUO_BwFbfOScwS8eholmes4aReUragKPsYAg5iCGfPOMrRwXOzEErtYYhckH1Jn0dsH_7kfQf-V_Mk5Ax9WAPJCbg0EEZWBvF1tAqgktDeP-f8CgVbF-A</recordid><startdate>201206</startdate><enddate>201206</enddate><creator>Saha, S.</creator><creator>Hollands, W.</creator><creator>Needs, P.W.</creator><creator>Ostertag, L.M.</creator><creator>de Roos, B.</creator><creator>Duthie, G.G.</creator><creator>Kroon, P.A.</creator><general>Elsevier Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>7U7</scope><scope>C1K</scope></search><sort><creationdate>201206</creationdate><title>Human O-sulfated metabolites of (−)-epicatechin and methyl-(−)-epicatechin are poor substrates for commercial aryl-sulfatases: Implications for studies concerned with quantifying epicatechin bioavailability</title><author>Saha, S. ; Hollands, W. ; Needs, P.W. ; Ostertag, L.M. ; de Roos, B. ; Duthie, G.G. ; Kroon, P.A.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c389t-e16cfc75e14e6a0ac2ecee1255671df6782d01b081c4d7e2a35a1c9bc45422d73</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><topic>Absorption</topic><topic>Administration, Oral</topic><topic>Arylsulfatases - metabolism</topic><topic>Biological Availability</topic><topic>Biotransformation</topic><topic>Catechin - administration &amp; dosage</topic><topic>Catechin - analogs &amp; derivatives</topic><topic>Catechin - blood</topic><topic>Catechin - metabolism</topic><topic>Catechin - urine</topic><topic>Chromatography, Liquid</topic><topic>Cross-Over Studies</topic><topic>Dietary bioactives</topic><topic>England</topic><topic>Female</topic><topic>Flavonoids</topic><topic>Glucuronidase - metabolism</topic><topic>Human metabolism</topic><topic>Humans</topic><topic>Hydrogen-Ion Concentration</topic><topic>Hydrolysis</topic><topic>Male</topic><topic>Methylation</topic><topic>Phase-2 enzymes</topic><topic>Phenolics</topic><topic>Polyphenols</topic><topic>Reproducibility of Results</topic><topic>Substrate Specificity</topic><topic>Sulfuric Acid Esters - administration &amp; dosage</topic><topic>Sulfuric Acid Esters - blood</topic><topic>Sulfuric Acid Esters - metabolism</topic><topic>Sulfuric Acid Esters - urine</topic><topic>Tandem Mass Spectrometry</topic><topic>Time Factors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Saha, S.</creatorcontrib><creatorcontrib>Hollands, W.</creatorcontrib><creatorcontrib>Needs, P.W.</creatorcontrib><creatorcontrib>Ostertag, L.M.</creatorcontrib><creatorcontrib>de Roos, B.</creatorcontrib><creatorcontrib>Duthie, G.G.</creatorcontrib><creatorcontrib>Kroon, P.A.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>Toxicology Abstracts</collection><collection>Environmental Sciences and Pollution Management</collection><jtitle>Pharmacological research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Saha, S.</au><au>Hollands, W.</au><au>Needs, P.W.</au><au>Ostertag, L.M.</au><au>de Roos, B.</au><au>Duthie, G.G.</au><au>Kroon, P.A.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Human O-sulfated metabolites of (−)-epicatechin and methyl-(−)-epicatechin are poor substrates for commercial aryl-sulfatases: Implications for studies concerned with quantifying epicatechin bioavailability</atitle><jtitle>Pharmacological research</jtitle><addtitle>Pharmacol Res</addtitle><date>2012-06</date><risdate>2012</risdate><volume>65</volume><issue>6</issue><spage>592</spage><epage>602</epage><pages>592-602</pages><issn>1043-6618</issn><eissn>1096-1186</eissn><abstract>Epicatechin is a widely consumed dietary flavonoid and there is substantial evidence that it contributes to the health benefits reported for flavanol-rich cocoa products including dark chocolate. Numerous reports have described the appearance of epicatechin and epicatechin phase-2 conjugates (sulfates and glucuronides of epicatechin and methylepicatechin) in blood and urine samples of subjects following ingestion of epicatechin. The most widely reported method of quantifying total epicatechin in plasma and urine samples involves hydrolysis with a mixture of β-glucuronidase and sulfatase to convert the conjugates to epicatechin aglycone which is subsequently quantified. We observed a lack of hydrolysis of epicatechin sulfates and methylepicatechin sulfates using commercial sulfatases and investigated this further. Samples of urine or plasma from subjects who had consumed epicatechin were subjected to enzyme hydrolysis and then analysed using LC–MS/MS, or analysed without enzyme hydrolysis. Attempts to increase the extent of hydrolysis of epicatechin conjugates were made by increasing the amount of enzyme, hydrolysis pH and length of incubations, and using alternative sources of enzyme. The standard hydrolysis conditions failed to hydrolyse the majority of epicatechin sulfates and methylepicatechin sulfates. Even when the quantity of enzyme and incubation period was increased, the pH optimised, or alternative sources of sulfatases were used, epicatechin monosulfates and methylepicatechin monosulfates remained as major peaks in the chromatograms of the samples. An assessment of literature data strongly suggested that the majority of reports where enzyme hydrolysis was used had significantly underestimated epicatechin bioavailability in humans. Methods for quantifying epicatechin concentrations in blood and urine need to take account of the lack of hydrolysis of (methyl)epicatechin-sulfates, for example by quantifying these directly using LC–MS/MS.</abstract><cop>Netherlands</cop><pub>Elsevier Ltd</pub><pmid>22373658</pmid><doi>10.1016/j.phrs.2012.02.005</doi><tpages>11</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1043-6618
ispartof Pharmacological research, 2012-06, Vol.65 (6), p.592-602
issn 1043-6618
1096-1186
language eng
recordid cdi_proquest_miscellaneous_1837310464
source Elsevier ScienceDirect Journals Complete - AutoHoldings; MEDLINE
subjects Absorption
Administration, Oral
Arylsulfatases - metabolism
Biological Availability
Biotransformation
Catechin - administration & dosage
Catechin - analogs & derivatives
Catechin - blood
Catechin - metabolism
Catechin - urine
Chromatography, Liquid
Cross-Over Studies
Dietary bioactives
England
Female
Flavonoids
Glucuronidase - metabolism
Human metabolism
Humans
Hydrogen-Ion Concentration
Hydrolysis
Male
Methylation
Phase-2 enzymes
Phenolics
Polyphenols
Reproducibility of Results
Substrate Specificity
Sulfuric Acid Esters - administration & dosage
Sulfuric Acid Esters - blood
Sulfuric Acid Esters - metabolism
Sulfuric Acid Esters - urine
Tandem Mass Spectrometry
Time Factors
title Human O-sulfated metabolites of (−)-epicatechin and methyl-(−)-epicatechin are poor substrates for commercial aryl-sulfatases: Implications for studies concerned with quantifying epicatechin bioavailability
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T06%3A49%3A19IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Human%20O-sulfated%20metabolites%20of%20(%E2%88%92)-epicatechin%20and%20methyl-(%E2%88%92)-epicatechin%20are%20poor%20substrates%20for%20commercial%20aryl-sulfatases:%20Implications%20for%20studies%20concerned%20with%20quantifying%20epicatechin%20bioavailability&rft.jtitle=Pharmacological%20research&rft.au=Saha,%20S.&rft.date=2012-06&rft.volume=65&rft.issue=6&rft.spage=592&rft.epage=602&rft.pages=592-602&rft.issn=1043-6618&rft.eissn=1096-1186&rft_id=info:doi/10.1016/j.phrs.2012.02.005&rft_dat=%3Cproquest_cross%3E1010496084%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1010496084&rft_id=info:pmid/22373658&rft_els_id=S1043661812000230&rfr_iscdi=true